1. Home
  2. Live Updates
  3. Biologics

Live Breaking News & Updates on Biologics

Stay informed with the latest breaking news from Biologics on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Biologics and stay connected to the pulse of your community

China's CAR T market comes of age

Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation, business, financing, regulation, science, product development, clinical trials and more

Nanjing , Jiangsu , China , Chinese , Wuxi-apptec-co , Pharmaceuticals-inc , Juno-therapeutics-inc , Legend-biotech-corp , Johnson , Juventas-cell-therapy-ltd , Nanjing-legend-biotech-corp

Understanding Biologics for Patients With IBD

Experts discuss the warnings regarding IL-17 blockers and inflammatory bowel disease.

Biologics , Biologic-therapy , Oral-therapy , Shared-decision-making , Ibd , Il-17-blockers , Inflammatory-bowel-disease ,

Optimizing Patient Care in Atopic Dermatitis: The Role of Ruxolitinib and Educational Initiatives for Managed Care Professionals

The Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting included multiple poster presentations featuring studies on atopic dermatitis, 2 of which focused on the impact of ruxolitinib cream monotherapy and educating managed care professionals.

Louisiana , United-states , New-orleans , Michele-guadalupe , Healthcare-integrated-research-database , National-eczema-association , Impact-education , Academy-of-managed-care-pharmacy , Managed-care-pharmacy , Jinan-liu , Ruxolitinib-cream-reduce-corticosteroid , Biologic-use

Treatment of Generalized Pustular Psoriasis (GPP)

Kanya Oul shares how her generalized pustular psoriasis (GPP) was initially treated and Drs Tina Bhutani and Scott Boswell discuss available treatment options for GPP.

J-scott-boswell , Tina-bhutani , Kanya-oul , Generalized-pustular-psoriasis , Gpp , Inflammatory-disease , Gpp-flares , Systemic-disease , Systemic-retinoid , Broad-immunosuppressants , Targeted-therapy

IL-17A Inhibition Shown to be Superior for Biologic-Naïve Psoriatic Arthritis Patients

Despite these conclusions, this meta-analysis also showed that those receiving PDE4 inhibitors were the least likely to report adverse events.


Ningbo , Zhejiang , China , Ottawa , Ontario , Canada , Jixia-lin , Cochrane-library , Psa , Psoriatic-arthritis , Meta-analysis , Biologics

A look at drug development in Alzheimer's disease

Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation, business, financing, regulation, science, product development, clinical trials and more

Howard-fillit , Auguste-deter , Alzheimer-drug-discovery-foundation , Biogen-inc , National-academies , Drug-discovery-foundation , Biologics , Iopharmaceutical , Iotechnology , Rug , Ma , Da

Accelerating biologics to market: The importance of GMP-compliant contract research organizations

In this interview, NewsMedical speaks with Ben Tyrrell about how GMP-compliant contract research organizations are facilitating rapid entry into the biologics market.

Ben-tyrrell , Maria-osipova , Quality-department , Sartorius-united-kingdom-ltd , Contract-research-organizations , Sponsored-content , Contract-research , Good-manufacturing-practices , United-kingdom , Senior-scientist , Antibody-dependent-cellular-phagocytosis , Image-credit

Sequence Study of Risankizumab vs Ustekinumab in CD

David Rubin, MD, leads the panel discussion on a head-to-head sequence study of rizankizumab vs ustekinumab in the treatment of CD, as well as approaches to choosing first-line treatment.

Marla-dubinsky , David-rubin , Miguel-regueiro , Remo-panaccione , Sara-horst , Crohn-x27s-disease , Cd , Il-12 , Il-23 , Sequence , Ustekinumab

Samsung chief visits biotech drug arm

Samsung Electronics Chairman Lee Jae-yong on Friday visited Samsung Biologics, a biotech drug unit of Samsung Group, marking his first local schedule since he was acquitted in connection with the controversial 2015 merger of two affiliates.

Seoul , Soult-ukpyolsi , South-korea , Cheil , Kangwon-do , Songdo-incheon , Lee-jae-yong , Samsung-biologics , Samsung-electronics , Courtesy-of-samsung-electronics , Cheil-industries-inc , Samsung-group

Anti-TNF and Anti-Integrins for Treatment of CD

Experts in gastroenterology provide an overview of anti-TNF (tumor necrosis factor) and anti-integrin therapies in treatment of CD.

Remo-panaccione , David-rubin , Sara-horst , Miguel-regueiro , Marla-dubinsky , Crohn-x27s-disease , Cd , Anti-tnf , Anti-integrin , Infliximab , Adalimumab